Trials / Completed
CompletedNCT00670436
The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions
The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- University of Ulm · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to assess the safety and efficacy of a Paclitaxel-eluting PTCA-balloon in combination with bare-metal stenting for treatment of chronic total occlusions in native coronary arteries with reference diameters between 2.5 mm and 4.0 mm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | paclitaxel eluting PTCA balloon catheter (SeQuent Please) | paclitaxel eluting PTCA balloon catheter after bare-metal stenting of chronic total occlusion in a native coronary artery |
| DEVICE | paclitaxel eluting Taxus stent (Boston Scientific) | paclitaxel-eluting Taxus stents (Boston Scientific) in chronic total occlusion in native coronary arteries |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-09-01
- Completion
- 2014-03-01
- First posted
- 2008-05-01
- Last updated
- 2014-06-10
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00670436. Inclusion in this directory is not an endorsement.